In January 2013 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4140 (the Athlete) after he refused and failed to submit to sample collection.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Korean Athlete is since September 2011 residing in Japan, working as a coach and able to speak the Japanes language basically but he can’t read Japanese written documents. The Athlete was selected in February 2013 at a Taekwondo competition in Japan to provide a sample for drug testing. Initially the Athlete cooperated but he failed to produce a sample in the presence of the Doping Control Officer. Due to the delays and a return flight he had to catch the Athlete decided not to complete the sample collection and he left the Doping Control Station in spite of the warnings of the Doping Control Officer.

The Athlete stated that during the sample collection and due to the delays at the Doping Control Station he followed the advice of the chairperson of his Taekwondo Association who told him to leave without completing the sample collection. The Athlete asserted that he had misunderstood the implications of his violation because he expected only to be excluded for competitions but instead he was completely suspended including for his work as a coach.

Without grounds that justify his violation the Japan Anti-Doping Disciplinary Panel decides on 14 May 2013 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 7 April 2013.

In January 2013 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4139 (the Athlete) after her sample tested positive for the prohibited substance erythropoietin (EPO). After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated, sustained by medical files, that the erythropoieting was administered as treatment for her anemia. The Athlete asserted that she was unaware of the EPO in her body because her doctor didn’t inform her that he had administered this substance.
The Panel finds that the athlete failed to mention to her doctor that she was an athlete and subject to doping tests and failed to inquire with her doctor about the medication he wanted to administer.
Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 14 May 2013 to impose a 1 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 18 January 2013.

Related case:
JADDP 2011-003 JADA vs J-4128
July 17, 2011

In December 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4128 (the Athlete) after her sample tested positive for the prohibited substances 19-norandrosterone and 19-noretiocholanolone. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete asserted that a possible source of the prohibited substances were the supplements she had used and the injections administered as treatment for her injury in September 2012.
The Panel concludes that there is no proof that the use was intentional and that she failed to explain how the prohibited substances entered her body.

Because the Athlete J-4128 was previously sanctioned in July 2011 this is her second violation and therefore the Japan Anti-Doping Disciplinary Panel decides on 27 December 2012 to impose a 5 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 14 December 2012.

In December 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4137 (the Athlete) after her sample tested positive for the prohibited substance methylephedrine. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated that she suffered from a cold and coughing and therefore had used prescribed medication as treatment. The Panel finds that the violation was non intentional and that the Athlete acted at fault because she failed to mention to her doctor that she was an athlete and subject of doping tests and took the medication that was not prescribed to herself.

Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 19 December 2012 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 December 2012.

In September 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4136 (the Athlete) after his sample tested positive for the prohibited substance 19-norandrosterone. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated that he has used non prescribed supplements purchased overseas on the internet.
With significant fault or negligence the Japan Anti-Doping Disciplinary Panel decides on 4 October 2012 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 27 September 2012.

In September 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4135 (the Athlete) after his sample tested positive for the prohibited substance furosemide. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated that he has used a herbal medication purchased on the internet as treatment for his insomnia.
Considering the Athlete's negligence and his statement the Japan Anti-Doping Disciplinary Panel has his doubts that the use was non intentional and decides on 28 September 2012 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 18 September 2012.

In July 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4134 (the Athlete) after his sample tested positive for the prohibited substance Methylephedrine. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete admitted that he had used an over-the-counter medication as treatment for his cough on the day before the sample collection.
The Panel finds that the violation was non intentional and that the Athlete had failed to duly research the ingredients of the medication before using because the label of the medication clearly mentioned the prohibited substance dl methylephedrine hydrochloride.

Considering the Athletes negligence the Japan Anti-Doping Disciplinary Panel decides on 1 August 2012 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 25 July 2012.

In May 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4133 (the Athlete) after he refused or failed without compelling justification to provide a sample for drug testing. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel

The amateur Athlete was selected to provide a sample during a cycling competition in April 2012 but he already had left the competition after an accident, his fall from his bicycle and his disqualification in the race.
Later that day the Athlete’s coach managed to contact the Athlete who was riding home on his bicycle to inform him that he was selected but the sample collection was already finished.
Before the competition started the athletes had received information about the doping test from the Doping Control Officers. Not mentioned was that athletes who abandoned the competition could also be be selected to provide a sample.

The Panel finds that it was not desirable that the Athlete left to return home after being disqualified in the race and did not confirm whether he was selected to undergo testing. Neither does the Panel intend to fully deny the notification method generally used in the cycling world.
Considering the circumstances in this case the Panel concludes that the Athlete cannot be found to have received “notification as authorized in these Anti-Doping Rules” in Article 2.3, and therefore a violation of anti-doping rules as set forth in the Japan Anti-Doping Code cannot be found to have occurred.
The Japan Anti-Doping Disciplinary Panel decides on 4 June 2012 to cease the proceedings against the Athlete including the imposed provisional suspension.

In April 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4132 (the Athlete) after her sample tested positive for the prohibited substance clomiphene. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated, sustained by evidence, that she had used prescribed medication as treatment for her condition a month before she provided a sample.
With non intentional use the Panel finds that the Athlete failed to mention to her doctor that she was an athlete and subject to doping tests. Also she did not research the ingredients of her prescribed medication before using.

Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 15 April 2012 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 6 April 2012.

In January 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4131 (the Athlete) after his sample tested positive for the prohibited substance tamoxifen. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete asserted that the person with whom he was living suffered from a serous illness and instead of calcium he used by mistake his medication which was used as treatment for the illness.
The Panel did not accept the Athletes statement because he failed to produce evidence of a medical diagnosis about the illness or a valid prescription for the medication which was also personally imported by someone else.

Without grounds for reduction under the Rules the Japan Anti-Doping Disciplinary Panel decides on 7 February 2012 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 12 January 2012.